These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15664917)

  • 1. Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cells.
    Cheadle EJ; O'Donnell D; Selby PJ; Jackson AM
    Infect Immun; 2005 Feb; 73(2):784-94. PubMed ID: 15664917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid loss of early antigen-presenting activity of lymph node dendritic cells against Ag85A protein following Mycobacterium bovis BCG infection.
    Xu Z; Xia A; Li X; Zhu Z; Shen Y; Jin S; Lan T; Xie Y; Wu H; Meng C; Sun L; Yin Y; Chen X; Jiao X
    BMC Immunol; 2018 Jun; 19(1):19. PubMed ID: 29940854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells infected with Mycobacterium bovis bacillus Calmette Guerin activate CD8(+) T cells with specificity for a novel mycobacterial epitope.
    Feng CG; Demangel C; Kamath AT; Macdonald M; Britton WJ
    Int Immunol; 2001 Apr; 13(4):451-8. PubMed ID: 11282984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium bovis BCG and purified protein derivative-induced reduction in the CD80 expression and the antigen up-take function of dendritic cells from patients with cervical cancer.
    Manickam A; Sivanandham M
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):413-7. PubMed ID: 21824715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
    Ladel CH; Daugelat S; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria.
    Neyrolles O; Gould K; Gares MP; Brett S; Janssen R; O'Gaora P; Herrmann JL; Prévost MC; Perret E; Thole JE; Young D
    J Immunol; 2001 Jan; 166(1):447-57. PubMed ID: 11123323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation of endogenously synthesized MHC class II-restricted epitopes by MHC class II cancer vaccines is independent of transporter associated with Ag processing and the proteasome.
    Dissanayake SK; Tuera N; Ostrand-Rosenberg S
    J Immunol; 2005 Feb; 174(4):1811-9. PubMed ID: 15699107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunity.
    Mitsui H; Inozume T; Kitamura R; Shibagaki N; Shimada S
    J Invest Dermatol; 2006 Aug; 126(8):1804-12. PubMed ID: 16645583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of antigen presenting cells with mycobacteria.
    Hope JC; Thom ML; McCormick PA; Howard CJ
    Vet Immunol Immunopathol; 2004 Aug; 100(3-4):187-95. PubMed ID: 15207456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor vaccination in heterozygous congenic F1 mice: presentation of tumor-associated antigen by the two parental class I alleles.
    Carmon L; Tzehoval E; Tirosh B; el-Shami KM; Bar-Haim E; Vadai E; Feldman M; Eisenbach L
    J Immunother; 2000; 23(3):344-52. PubMed ID: 10838663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guerin and adjuvant activity in vivo.
    Sprott GD; Dicaire CJ; Gurnani K; Sad S; Krishnan L
    Infect Immun; 2004 Sep; 72(9):5235-46. PubMed ID: 15322018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterial infection of macrophages results in membrane-permeable phagosomes.
    Teitelbaum R; Cammer M; Maitland ML; Freitag NE; Condeelis J; Bloom BR
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15190-5. PubMed ID: 10611360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effects of Mycobacterium bovis BCG on Macrophages and Dendritic Cells from Murine Spleen.
    Xu Z; Meng C; Qiang B; Gu H; Sun L; Yin Y; Pan Z; Chen X; Jiao X
    Int J Mol Sci; 2015 Oct; 16(10):24127-38. PubMed ID: 26473844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
    Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
    Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapy.
    Young SL; Murphy M; Zhu XW; Harnden P; O'Donnell MA; James K; Patel PM; Selby PJ; Jackson AM
    Int J Cancer; 2004 Nov; 112(4):653-60. PubMed ID: 15382047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosis.
    Dhar N; Rao V; Tyagi AK
    FEMS Microbiol Lett; 2000 Sep; 190(2):309-16. PubMed ID: 11034297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.
    Johansen P; Fettelschoss A; Amstutz B; Selchow P; Waeckerle-Men Y; Keller P; Deretic V; Held L; Kündig TM; Böttger EC; Sander P
    Clin Vaccine Immunol; 2011 Jun; 18(6):907-13. PubMed ID: 21471301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.